4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-011225
CEO and CFO bought 2,500 shares at $19.98 ($49,950)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2024-03-22 | Purchase | +2,500 | $19.98 | $49,950 | 5,347,777 | D |
| Open-market purchases · 2,500 sh · avg $19.98 · $49,950 | |||||||
Loading xslF345X05/ownership.xml…